EMU002

N/A

Report date: 2025/10/15 17:03:29

Base Information

Drug NameEMU002
Drug Alias NameEMU-002
ClassificationCell and gene therapy > Gene therapy
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsRett Syndrome
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesEmugen Therapeutics LLC
China Registration ClassN/A

Develop Information

Active CompaniesEmugen Therapeutics LLC
Inactive CompaniesN/A
Active IndicationsRett Syndrome
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A